Pharmacology, Toxicology and Addiction MedicineTier 1Approach to a presentation

Delirium (agitated or hypoactive)

Red flags

  • Agitated delirium with hyperthermia and autonomic instability - sympathomimetic/serotonergic/anticholinergic toxicity
  • Delirium tremens (48-96h post last drink) - untreated mortality 1-5%
  • Hypoactive delirium mistaken for depression/fatigue - opioid, benzodiazepine, or anticholinergic accumulation
  • Rigidity + fever + delirium - NMS

Differential by mechanism

Toxidrome-based causes
  • Anticholinergic: agitated delirium, mydriasis, dry hot skin, urinary retention, tachycardia - "mad as a hatter, red as a beet, dry as a bone"
  • Sympathomimetic: agitation, mydriasis, tachycardia, hyperthermia (stimulants, cocaine)
  • Sedative-hypnotic withdrawal: alcohol, benzodiazepine - agitated, tremor, autonomic hyperactivity, hallucinations
  • Opioid/sedative intoxication or accumulation: hypoactive, miotic (opioid) or normal pupils, respiratory depression
Drug accumulation in the elderly
  • Anticholinergic burden (multiple mildly anticholinergic drugs), opioid accumulation in renal impairment, benzodiazepine accumulation
Other
  • Serotonin syndrome, NMS, corticosteroid-induced delirium/psychosis

Focused history

  • New drug, dose increase, or renal/hepatic impairment altering clearance
  • Alcohol/benzodiazepine use and timing of last dose
  • Baseline cognition (acute change is the key discriminator from dementia)
  • Full medication reconciliation for cumulative anticholinergic/sedative burden

Focused examination

  • CAM (Confusion Assessment Method) - acute onset, fluctuation, inattention +/- disorganised thinking or altered consciousness
  • Pupils, skin (dry vs diaphoretic), temperature, tone, reflexes
  • Bowel sounds, urinary retention (anticholinergic)

Investigation strategy

  • Exclude organic causes first - glucose, UEC, calcium, infection screen, oxygenation
  • Drug levels where relevant (digoxin, lithium)
  • ECG if QT/QRS-affecting drugs on board

Management

1. Treat the reversible cause
  • Stop/reduce causative drug(s); correct metabolic derangement; treat withdrawal per specific protocol (alcohol/benzodiazepine)
2. Agitated delirium
  • Verbal de-escalation and environmental measures first
  • Benzodiazepines for sedative/alcohol withdrawal delirium specifically
  • Avoid benzodiazepines in most other causes of delirium (worsens confusion) - use low-dose antipsychotic (haloperidol, olanzapine) if pharmacological sedation needed and not anticholinergic/serotonergic in origin
  • Physical restraint only as last resort, minimise duration
3. Hypoactive delirium
  • Easily missed - screen for it, treat the underlying cause, avoid further sedating drugs
  • Optimise sleep-wake cycle, mobilise early, correct sensory deficits (glasses, hearing aids)
4. Specific reversal
  • Physostigmine for severe anticholinergic delirium (specialist use, risk of cholinergic crisis/seizure - reserve for refractory cases)

Traps

  • Benzodiazepines worsen most delirium except alcohol/sedative withdrawal - a common prescribing error
  • Hypoactive delirium is under-recognised and often mislabelled as depression or "just tired"
  • Anticholinergic delirium can be worsened by antipsychotics with their own anticholinergic activity (e.g., olanzapine) - choose a lower-anticholinergic agent if antipsychotic needed
  • Physical restraint increases agitation and injury risk - use only when de-escalation and pharmacological measures have failed

Talk track

1. Match the sedative to the cause

  • "Benzodiazepines are for withdrawal delirium specifically - elsewhere they usually make confusion worse."

2. Look actively for hypoactive delirium

  • "The quiet, withdrawn patient gets the same CAM screen as the agitated one."

8 of 8 sections written · drafted 2026-09-13